BENITEC BIOPHARMA

In News

Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®

CGTLive® - Apr 19, 2026

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Yahoo Finance

Yahoo Finance - Feb 14, 2026

Hedge funds owners may consider drastic measures as Benitec Biopharma Inc.'s (NASDAQ:BNTC) recent US$60m drop adds to long-term losses - simplywall.st

simplywall.st - Feb 14, 2026

Benitec Biopharma Stock (BNTC) Opinions on $100M Stock Offering - Quiver Quantitative

Quiver Quantitative - Nov 11, 2025

Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade - Seeking Alpha

Seeking Alpha - Jan 31, 2026

Mintz Advises on Benitec Biopharma’s $80 Million Follow-On Offering and Concurrent $20 Million Registered Direct Offering - Mintz

Mintz - Nov 12, 2025

Benitec BioPharma stock maintains Buy rating on positive trial data - Investing.com

Investing.com - Mar 09, 2026

Benitec Biopharma (BNTC) Reports Promising Results from BB-301 S - GuruFocus

GuruFocus - Jan 11, 2026

Evaluating Durable Dysphagia Outcomes in OPMD: Insights From Early BB-301 Clinical Data - NeurologyLive

NeurologyLive - Jan 24, 2026

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301 - Yahoo Finance

Yahoo Finance - Nov 03, 2025

Jerel A. Banks, MD, PhD, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®

CGTLive® - Mar 13, 2026

BENITEC BIOPHARMA ($BNTC) Releases Q2 2026 Earnings - Quiver Quantitative

Quiver Quantitative - Feb 12, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment